265 related articles for article (PubMed ID: 18258586)
21. Effective use of alteplase for occluded tunneled venous catheter in hemodialysis patients.
Mendes ML; Castro JH; Silva TN; Barretti P; Ponce D
Artif Organs; 2014 May; 38(5):399-403. PubMed ID: 24117542
[TBL] [Abstract][Full Text] [Related]
22. The use of alteplase to restore patency of central venous lines in pediatric patients: a cohort study.
Choi M; Massicotte MP; Marzinotto V; Chan AK; Holmes JL; Andrew M
J Pediatr; 2001 Jul; 139(1):152-6. PubMed ID: 11445811
[TBL] [Abstract][Full Text] [Related]
23. Clinical outcomes of management of CVAD occlusions.
Peng C; Monagle P; Newall F
Arch Dis Child; 2011 Sep; 96(9):885-7. PubMed ID: 21398316
[TBL] [Abstract][Full Text] [Related]
24. Alteplase (Cathflo Activase).
Middleton G; Ruzevick B
Clin J Oncol Nurs; 2004 Aug; 8(4):417-8, 420. PubMed ID: 15354930
[No Abstract] [Full Text] [Related]
25. Preventing central line-associated bloodstream infections and the Joint Commission's Home Care National Patient Safety Goals.
McGoldrick M
Home Healthc Nurse; 2009 Apr; 27(4):220-8; quiz 229-30. PubMed ID: 19387288
[No Abstract] [Full Text] [Related]
26. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
Marder VJ
Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
[TBL] [Abstract][Full Text] [Related]
27. Urokinase: new indication. Thrombosed venous and dialysis catheters: when heparin fails. Urokinase clears about 75% of thrombosed venous catheters intended for long-term use with a dose-related increase in the bleeding risk.
Prescrire Int; 2009 Jun; 18(101):118. PubMed ID: 19637430
[No Abstract] [Full Text] [Related]
28. Antithrombosis management in community-dwelling elderly: improving safety.
Bockwoldt D
Geriatr Nurs; 2010; 31(1):28-36. PubMed ID: 20159351
[TBL] [Abstract][Full Text] [Related]
29. Restoring patency to central venous access devices.
Cummings-Winfield C; Mushani-Kanji T
Clin J Oncol Nurs; 2008 Dec; 12(6):925-34. PubMed ID: 19064386
[TBL] [Abstract][Full Text] [Related]
30. A novel approach to central venous catheter thrombosis in a patient with cystic fibrosis.
Hull JH; Tucker W; Hatrick AG; Knight RK; Ho TB
J Cyst Fibros; 2007 Nov; 6(6):417-8. PubMed ID: 17379581
[TBL] [Abstract][Full Text] [Related]
31. Treatment of catheter occlusion in pediatric patients.
Kerner JA; Garcia-Careaga MG; Fisher AA; Poole RL
JPEN J Parenter Enteral Nutr; 2006; 30(1 Suppl):S73-81. PubMed ID: 16387916
[TBL] [Abstract][Full Text] [Related]
32. Commentary on 'Interventions for restoring patency of central venous catheter lumens'.
Bauman ME; Massicotte MP
Evid Based Child Health; 2013 Mar; 8(2):750-1. PubMed ID: 23877888
[TBL] [Abstract][Full Text] [Related]
33. Techniques in dosing for thrombolysis of occluded central venous catheters.
Haire WD
Tech Vasc Interv Radiol; 2001 Jun; 4(2):127-30. PubMed ID: 11981800
[TBL] [Abstract][Full Text] [Related]
34. Using alteplase to clear occlusions.
Moureau N
Nursing; 2002 Jan; 32(1):73. PubMed ID: 12926500
[No Abstract] [Full Text] [Related]
35. Efficacy and safety of intrapleural instillation of alteplase in the management of complicated pleural effusion or empyema.
Thommi G; Nair CK; Aronow WS; Shehan C; Meyers P; McLeay M
Am J Ther; 2007; 14(4):341-5. PubMed ID: 17667208
[TBL] [Abstract][Full Text] [Related]
36. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? No.
Agnelli G; Verso M
J Thromb Haemost; 2006 Jan; 4(1):14-5. PubMed ID: 16409443
[No Abstract] [Full Text] [Related]
37. Coagulation disorders - recent lessons from clinical conditions.
Scharf RE
Hamostaseologie; 2015; 35(4):301-2. PubMed ID: 26536622
[No Abstract] [Full Text] [Related]
38. Prophylactic rtPA in the Prevention of Line-associated Thrombosis and Infection in Short Bowel Syndrome.
Malec LM; Cooper J; Rudolph J; Michaels MG; Ragni MV
J Pediatr Gastroenterol Nutr; 2018 Jun; 66(6):972-975. PubMed ID: 29135819
[TBL] [Abstract][Full Text] [Related]
39. Review of tissue plasminogen activator, ischemic stroke, and potential legal issues.
Liang BA; Lew R; Zivin JA
Arch Neurol; 2008 Nov; 65(11):1429-33. PubMed ID: 19001160
[TBL] [Abstract][Full Text] [Related]
40. Is antithrombotic prophylaxis required in cancer patients with central venous catheters? Still an open question.
Levine M
J Thromb Haemost; 2006 Jan; 4(1):16-8. PubMed ID: 16409444
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
